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Chemical risk estimation requires quantitative information on exposures and tox-
icological effects. Quantitative exposure information can include chemical intake 
rates and (bio)monitoring data; however, such information does not exist for the 
vast majority of marketed chemicals. In addition to limited exposure data there 
is limited information on chemical use patterns and production and emission 
quantities. These data gaps require the application of mass balance, statistical and 
quantitative structure-activity relationship (QSAR) models to predict exposure 
and exposure potential for humans and ecological receptors. Models and model-
ling frameworks that can be parameterized and used for high-throughput screen-
ing (HTS) with the currently available (limited) chemical information are being 
developed and evaluated to obtain essential estimates of exposure for data poor 
chemicals. This presentation provides an introduction to underlying principles of 
some models used for exposure- and risk-based HTS for chemical prioritization for 
human health, including tools used in the ExpoDat project (USEtox, RAIDAR, 
CalTox) and other initiatives (SHEDS-HT). Case study examples of HTS include 
(i) model applications for screening thousands of chemicals for far-field human 
exposure, (ii) comparisons of far-field and near-field human exposure model results, 
and (iii) model evaluations with biomonitoring and monitoring data. These illus-
trations show how the current tools can be used in a regulatory setting and what 
improvements in the models and chemical information used to parameterize the 
models are needed to address uncertainty in HTS exposure estimation.
 2447 The Impact of Rapid Bioactivity-Exposure-Based 
Prioritization on Chemical Safety
S. M. Knott. Office of Science Coordination and Policy, Exposure Assessment 
Coordination and Policy Division, US EPA, Washington, DC. Sponsor: B. 
Wetmore.
In 1996, several federal mandates including amendments to The Federal Food 
Drug and Cosmetic Act and the Safe Drinking Water Act identified the need to 
screen thousands of chemicals for their ability to perturb the endocrine system. 
Development of the Endocrine Disruptor Screening Program (EDSP) ensued to 
identify strategies to screen this universe of untested chemicals and has identified 
the utility of high throughput screening (HTS) and in silico tools to inform the 
process. The Environmental Protection Agency’s (EPA) EDSP (i.e., ToxCast) has 
strived to incorporate transparency in data generation, processing and analysis, 
requesting comments from a Federal Insecticide, Fungicide and Rodenticide Act 
Scientific Advisory Panel (FIFRA SAP) review in January 2013. Recent advances 
in bioactivity identification have been coupled with advances in HT toxicokinetic 
(HTTK) methods and HT exposure (HTE) estimation (e.g., ExpoCast) tools 
(reviewed by a FIFRA SAP in July 2014). EPA is now proposing an Integrated 
Endocrine Bioactivity and Exposure-Based approach for prioritization and screen-
ing in which (1) in vitro HTS data identify potential targets; (2) HTTK methods 
estimate external doses that achieve internal concentrations sufficient for bioactiv-
ity; and (3) putative bioactive doses are then directly compared to HTE predictions 
to estimate likelihood of exposures that cause bioactivity. Chemicals where the 
putative human bioactive dose is comparable to HTE predictions become targets 
for further study. This approach will include several datasets and considerations 
to probe critical points along the Adverse Outcome Pathway (AOP) for endocrine 
modalities. Such an approach is anticipated to address not only the needs of the 
EDSP but also holds potential to inform other source to outcome pathway issues of 
note to the Agency. This talk will outline this strategy and discuss its impact from 
a policy perspective, addressing its value to stakeholders in public and scientific 
communities. This abstract does not necessarily reflect U.S. EPA policy.
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Context of High-Throughput Screening (HTS): Concepts, 
Challenges, and Approaches
L. Aylward1 and S. Hays2. 1Summit Toxicology, LLP, Falls Church, VA and 
2Summit Toxicology, LLP, Allenspark, CO.
Biomonitoring provides an integrated assessment of chemical exposure, reflect-
ing internal dose encountered from all exposure routes, but is resource intensive 
and focused on a relatively small universe of “well-studied” chemicals. Creative 
approaches to design of biomonitoring studies, interpretation of in vitro toxico-
logically relevant exposure levels in the context of biomonitored matrices, and 
development of broader tools for prediction of toxicokinetic properties of da-
ta-poor chemicals are needed to enhance the utility of biomonitoring in population 
chemical exposure and risk assessment in an HTS framework. In vitro tested con-
centrations have been compared to blood concentrations in previous assessments, 
suggesting that blood-based concentrations of HTS compounds can be compared 
to in vitro active concentrations as a prioritization tool. Strategies for use of bio-
monitoring can move away from comprehensive population-based sampling to use 
of pooled serum sampling for screening and prioritization. Targeting analysis of 
pooled serum samples to achieve detection limits below active biological concen-
trations can provide screening-level information for prioritization of chemicals for 
further exposure and dose-response evaluation. Study designs using pooled serum 
samples with replicate pools per demographic group can provide information on 
both central tendency and population variation of biologically relevant internal 
exposure levels for comparison to in vitro active concentrations. Empirical exam-
ination of existing biomarker datasets can inform likely population variation from 
the central tendency as a function of toxicokinetics for biomarker concentrations. 
For example, for persistent compounds, the ratio of 95th percentile population 
concentration to the population mean is seldom greater than 4; for non-persistent 
compounds this ratio can approach 30 or more. This talk will address challenges 
and outline approaches to further integration of biomonitoring in HTS-based ex-
posure and risk assessment.
 2449 Using Environmental and Biological Measurements to 
Develop Generalizable Relationships for Exposure Models
R. Rudel,  R. Dodson and J. Brody. Silent Spring Institute, Newton, MA.
Comparing high-throughput exposure predictions with National Health and 
Nutrition Examination Survey (NHANES) data shows that consumer use is an 
influential variable, even when defined crudely. It follows that more sophisticated 
modeling of consumer exposure will reduce uncertainties in risk estimates, and 
so “near-field” exposure models are being developed. This talk will illustrate the 
use of environmental and biological measurement data to develop generalizable 
relationships that should be reflected in these models. First, we will demonstrate 
validation of indoor partitioning models for semivolatile organic chemicals based 
on simultaneous measures of 60 analytes, including a variety of chemical classes, 
in indoor air and house dust from 170 homes in two geographic regions. For 
phthalates, pesticides, PCBs, and flame retardants, simultaneously collected bio-
monitoring data allows us to identify key exposure determinants. Second, we will 
use NHANES and environmental measurements to describe population exposure 
variation and explore how to balance reducing model uncertainty with accurately 
predicting the highest-exposed subpopulations, since exposure distributions are 
often markedly skewed and can include extreme values. Finally, many consumer 
product chemical exposures are correlated, either because the chemicals co-occur 
in products or because of consumer behaviors. We will present key examples of 
mixtures at multiple levels, including from measurements of consumer products, 
indoor media, and biomonitoring, and discuss implications for exposure modeling 
and risk assessment.
 2450 Microphysiological Models of the Developing Nervous 
System: Biologically Driven Assembly Inspired by 
Embryology and Translated to Human Developmental 
Toxicology
T. B. Knudsen1 and W. Slikker2. 1NCCT, US EPA, Research Triangle Park, NC 
and 2NCTR, US FDA, Jefferson, AR.
Recent advances using human stem cells and other cells that can be ushered through 
differentiation and developmental maturation offer an unprecedented opportunity 
to develop predictive systems for toxicological assessment. The use of human cells 
is an advantage because there is no need to extrapolate across species, but even so, 
there may be the requirement that different cell types interact in a three-dimen-
sional (3D) relationship in order to provide prediction of the intact human. For 
